Riskpilot← Back to searchSign inGet full accessSciQuest Global AB
ABActiveOrg 5592821812Bagarbyvägen 11 DWholesale of pharmaceutical and medical goods · NACE 4646Est. 20200 employees
Revenue 2025
SEK 22K
+1240% vs 2024
EBITDA margin
-22.5%
-53% vs 2024
Equity ratio
100.0%
Financial strength
Net profit 2025
SEK -5K
-53% vs 2024
| Revenue | SEK 22K | +1240% |
| EBITDA | SEK -5K | -53% |
| Net profit | SEK -5K | -53% |
| Total assets | SEK 17K | -23% |
| Equity | SEK 17K | -23% |
| Employees | 0 | — |
Legal name
SciQuest Global AB
Org number
5592821812
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
11 november 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska verka som en digital marknadsplats inom life science- och biotekniksektorn. Bolgets verksamhet omfattar försäljning, upphandling, distribution och leverans av forskningsrelaterade tjänster, digitala och mjukvarulösningar, förbrukningsvaror, utrustning och om varor inom life science- och biotekniksektorn.
Address
Bagarbyvägen 11 D
Email
suvee.s@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 5 | 0 | 2 | 22 |
| Staff expenses | — | — | — | — |
| EBITDA | −7 | −9 | −3 | −5 |
| Depreciation & amort. | −0 | −0 | — | — |
| EBIT | −7 | −9 | −3 | −5 |
| Net financials | — | — | 0 | 0 |
| Profit before tax | −7 | −9 | −3 | −5 |
| Tax | −0 | −0 | — | — |
| Net profit | −7 | −9 | −3 | −5 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 17 | 25 | 22 | 17 |
| Equity | 18 | 25 | 22 | 17 |
| Long-term debt | 0 | 0 | — | — |
| Short-term debt | 2 | 0 | 0 | 0 |
| Total debt | 2 | — | — | — |
EBITDA margin
-22.5%
This company
15.8%
Market median
-242% vs market
20222025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20222025
Return on equity
-29.3%
This company
18.4%
Market median
-259% vs market
20222025
Net profit margin
-22.5%
This company
8.1%
Market median
-378% vs market
20222025
Asset turnover
1.30×
This company
1.12×
Market median
+16% vs market
20222025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2020-11-01 – 2022-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SV Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (3) | ||
PM Chief Executive Officer | Chief Executive Officer | 2024 – 2024 |
SS Chief Executive Officer | Chief Executive Officer | 2024 – 2025 |
HA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2024 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SciQuest Global AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Swetha Vijayaraghavan | Chief Executive Officer | 0 companies |
| Pranay Mogathal Ramachandra | Chief Executive Officer | 0 companies |
| Subu Surendran Rajasekaran | Chief Executive Officer | 0 companies |
| Hardik Abhaykumar Jangada | Deputy Chief Executive Officer | 0 companies |
| Antony Benedic Riyency Dirose | Deputy Board Member | 0 companies |
| Mounika Venkatasami Babu | Deputy Board Member | 0 companies |